Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Genomics

Roche acquires gene-sequencing firm Stratos Genomics

by Craig Bettenhausen
May 29, 2020 | A version of this story appeared in Volume 98, Issue 21

 

In a bid to accelerate its nanopore gene-sequencing technology, Roche has purchased Stratos Genomics for an undisclosed sum. Seattle-based Stratos brings its “sequencing by expansion” chemistry, which inserts large reporter molecules between the bases on a DNA strand. Different reporters bind to the four different DNA bases. Stratos says its platform increases the signal-to-noise ratio of nanopore sequencing, one of multiple competing next-generation gene-sequencing methods. The technology could have applications in personalized medicine and rapid response to future pathogens.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.